Shanghai, China

Youhong Hu

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Shangahi, CN (2015)
  • Shanghai, CN (2013 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Youhong Hu: A Pioneer in Pharmaceutical Compounds

Introduction

Youhong Hu is a notable inventor based in Shanghai, China, recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Hu has focused on developing innovative compounds that target viral infections and cancer treatment.

Latest Patents

Among his latest patents is a phthalazinone compound, which includes a method for its preparation, a pharmaceutical composition, and its use. This compound is designed to target viral nucleocapsids, effectively inhibiting the replication of viruses, particularly HBV. It demonstrates potent activity against HBV DNA replication and shows promising liver targeting capabilities. Another significant patent involves an o-aminoheteroaryl alkynyl-containing compound, which exhibits high inhibitory activity against FGFR and RET, along with a relatively low KDR activity. This compound has shown strong efficacy in inhibiting growth in various cancer cell lines, indicating its potential as a therapeutic agent.

Career Highlights

Youhong Hu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His innovative approach to drug design has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of antiviral and anticancer therapies.

Collaborations

Hu has collaborated with esteemed colleagues, including Bo Chao and Liguang Lou, to advance his research and enhance the impact of his inventions.

Conclusion

Youhong Hu's work exemplifies the intersection of innovation and practical application in medicine. His patents reflect a commitment to addressing critical health challenges through scientific discovery and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…